No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Fremont Bank Foundation Donates $750,000 to St. Rose Hospital Foundation

To Enhance Its Cardiac Catheterization Laboratory Equipment

Editor: What To Know

  • , is a STEMI (ST-elevation myocardial infarction) Receiving Center—a designation only given to hospitals where staff can meet rigorous standards of transferring a patient to the cardiac catheterization lab from the emergency room in 90 minutes or less.
  • Rose Hospital Foundation for the hospital to purchase a new catalyst cardiac catheterization laboratory machine while keeping services available to Bay Area patients.
  • Rose Hospital Foundation regularly receives emergency transports of patients from its facility and other Bay Area hospitals who are suffering from heart attacks and are in need of lifesaving cardiac procedures.

Fremont Bank Foundation recently donated $750,000 to its community partner St. Rose Hospital Foundation for the hospital to purchase a new catalyst cardiac catheterization laboratory machine while keeping services available to Bay Area patients.

The innovative Philips Azurion 7 C20 replaces an older cardiac catheterization model recently rendered obsolete.

St. Rose Hospital Foundation regularly receives emergency transports of patients from its facility and other Bay Area hospitals who are suffering from heart attacks and are in need of lifesaving cardiac procedures. St. Rose Hospital, located in Hayward, Calif., is a STEMI (ST-elevation myocardial infarction) Receiving Center—a designation only given to hospitals where staff can meet rigorous standards of transferring a patient to the cardiac catheterization lab from the emergency room in 90 minutes or less.

“Health-care workers need access to the most state-of-the-art equipment in order to provide high-quality services to our patients,” said Michael Cobb, St. Rose Hospital Foundation Executive Director. “Fremont Bank Foundation’s generous contribution allows us to quickly replace an outdated machine while ensuring a seamless continuation of providing top care to the residents of Alameda County and beyond.”

Every year, St. Rose Hospital doctors and nurses perform, on average, more than 400 cardiac diagnostic procedures and manage over 200 STEMI emergencies. In 2021, catheterization laboratory personnel conducted upward of 2,600 non-urgent and emergent cardiac procedures.

“St. Rose Hospital is a vital part of our Alameda County ecosystem, and we really listened when its Foundation expressed the importance behind upgrading the catheterization lab machine,” said Brian Hughes, Fremont Bank Executive Vice President and Foundation President and Executive Director. “This significant gift is one that will keep serving the health of our Bay Area community for years to come.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy